HOME‎ > ‎SRSAN NEWSLETTER‎ > ‎

CPAP Therapy Effect May be Comparable to Oral Diabetes Medication

posted May 22, 2015, 11:38 AM by Admin SRSAN   [ updated May 22, 2015, 11:41 AM ]


A study conducted at the University of Chicago demonstrated that with optimal use, one week of CPAP therapy reduced the mean 24-hr glucose levels and improved post-breakfast glucose response, as well as lowering the "dawn phenomenon" by 45% in type 2 diabetic patients with obstructive sleep apnea. In some patients, these effects were comparable to those produced by prescribed oral medications - a significant finding given that approximately 70% of type 2 diabetes patients suffer from OSA.

The National Health Sleep Awareness Project, an initiative funded by the Centers for Disease Control and Prevention in collaboration with the American Academy of Sleep Medicine, is advising all patients with Type 2 diabetes to be aware of their increased risk for obstructive sleep apnea, look for warning signs such as snoring, gasping or choking in their sleep and/or excessive daytime sleepiness, and talk to their doctor about further screening or testing for this chronic condition. According to Dr. Morgenthaler, president of the American Academy of Sleep Medicine, diagnosis and effective treatment of obstructive sleep apnea can improve glucose control and insulin sensitivity, helping patients better manage their diabetes.

Source: http://www.aasmnet.org/articles.aspx?id=5175
Comments